INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. – ACB GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact […]
(NasdaqGM:IOVA), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – RCKT GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the
(NASDAQ:DNUT), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines – TEM GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”)(NASDAQ:
(NYSE:ELV), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in DoubleVerify Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – DV GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against DoubleVerify Holdings, Inc. (“DoubleVerify” or the
(NASDAQ:AAPL), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-05197, is on behalf
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. – ALT GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines – VSTS GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or the “Company”) (NASDAQ: